Merck and Orna Therapeutics collaborate to advance Orna’s nextgen RNA technology
Collaboration supports multiple discovery efforts, including vaccines
Collaboration supports multiple discovery efforts, including vaccines
QIAstat-Dx Viral Vesicular Panel tests for six pathogens that produce similar symptoms
The card-to-cloud device was launched into the U.S. and many other markets and is designed to work without an embedded communications module.
The Trial, the first of its kind in Israel, recently obtained approval from the Israeli Ministry of Health and is preparing for participant recruitment.
WCK 5222 is a Super-drug which is entirely a new class of antibiotic known as "?-lactam ENHANCER".
The approved product has an estimated market size of around US$ 606 million for the twelve months ending June 2022, according to IQVIA.
Collaboration focuses on developing and implementing real-world research to drive patient access to cancer medicines
Company appoints five new independent directors to reconstituted board
ELCYS is the only FDA-approved cysteine hydrochloride injection on the market for use as an additive to amino acid solutions
Man lost 54 Kgs in 6 months with MGB procedure
Subscribe To Our Newsletter & Stay Updated